94 related articles for article (PubMed ID: 6403102)
21. Haemoglobin A1: An indicator of the metabolic control of diabetic patients.
Gonen B; Rubenstein A; Rochman H; Tanega SP; Horwitz DL
Lancet; 1977 Oct; 2(8041):734-7. PubMed ID: 71541
[TBL] [Abstract][Full Text] [Related]
22. Effect of tetrahydrocurcumin on insulin receptor status in type 2 diabetic rats: studies on insulin binding to erythrocytes.
Murugan P; Pari L; Rao CA
J Biosci; 2008 Mar; 33(1):63-72. PubMed ID: 18376071
[TBL] [Abstract][Full Text] [Related]
23. Genetic cause of hyperglycaemia and response to treatment in diabetes.
Pearson ER; Starkey BJ; Powell RJ; Gribble FM; Clark PM; Hattersley AT
Lancet; 2003 Oct; 362(9392):1275-81. PubMed ID: 14575972
[TBL] [Abstract][Full Text] [Related]
24. Insulin binding to erythrocytes in diabetic patients.
Okamoto M; Kuzuya H; Seino Y; Ikeda M; Imura H
Endocrinol Jpn; 1981 Apr; 28(2):169-73. PubMed ID: 7030723
[TBL] [Abstract][Full Text] [Related]
25. Haemoglobin A1 in diabetes mellitus.
Bartley PC; Hambling TE
Aust N Z J Med; 1979 Feb; 9(1):49-53. PubMed ID: 287443
[TBL] [Abstract][Full Text] [Related]
26. Erythrocytes: a new cell type for the evaluation of insulin receptor defects in diabetic humans.
Robinson TJ; Archer JA; Gambhir KK; Hollis VW; Carter L; Bradley C
Science; 1979 Jul; 205(4402):200-2. PubMed ID: 451590
[TBL] [Abstract][Full Text] [Related]
27. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
[TBL] [Abstract][Full Text] [Related]
28. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
Gastaldelli A; Nauck MA; Balena R
Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
[TBL] [Abstract][Full Text] [Related]
29. Metformin ameliorates extreme insulin resistance in a patient with anti-insulin receptor antibodies: description of insulin receptor and postreceptor effects in vivo and in vitro.
Di Paolo S
Acta Endocrinol (Copenh); 1992 Feb; 126(2):117-23. PubMed ID: 1543016
[TBL] [Abstract][Full Text] [Related]
30. [Value of combined subcutaneous infusion of insulin and metformin in 10 insulin-dependent obese diabetics].
Leblanc H; Marre M; Billault B; Passa P
Diabete Metab; 1987; 13(6):613-7. PubMed ID: 3329125
[TBL] [Abstract][Full Text] [Related]
31. Erythrocyte insulin binding abnormalities in fibro calculous pancreatic diabetes.
Ramachandran A; Susheela L; Mohan V; Kuzali DA; Viswanathan M
Horm Metab Res; 1988 Nov; 20(11):693-7. PubMed ID: 3063650
[TBL] [Abstract][Full Text] [Related]
32. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
Chazova I; Almazov VA; Shlyakhto E
Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
[TBL] [Abstract][Full Text] [Related]
33. Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide.
Beck-Nielsen H; Pedersen O; Lindskov HO
Acta Endocrinol (Copenh); 1979 Mar; 90(3):451-62. PubMed ID: 106617
[TBL] [Abstract][Full Text] [Related]
34. Rapid improvement in insulin binding to erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus during therapy.
Ramachandran A; Susheela L; Mohan V; Kuzhali DA; Viswanathan M
Acta Diabetol Lat; 1988; 25(3):205-14. PubMed ID: 3149105
[TBL] [Abstract][Full Text] [Related]
35. Insulin receptor defect in diabetic man with chronic renal failure: a comparison of erythrocyte insulin binding in diabetic and nondiabetic patients on maintenance hemodialysis.
Gambhir KK; Nerurkar SG; Cruz IA; Hosten AO
Biochem Med; 1981 Feb; 25(1):62-73. PubMed ID: 7013759
[No Abstract] [Full Text] [Related]
36. Changes in glycosylated haemoglobin after poor control in insulin-dependent diabetics.
Brooks AP; Nairn IM; Baird JD
Br Med J; 1980 Sep; 281(6242):707-10. PubMed ID: 7000273
[TBL] [Abstract][Full Text] [Related]
37. Effect of acute exercise on insulin binding to erythrocytes in type II diabetes.
Iwasaki M; Kobayashi M; Ohgaku S; Maegawa H; Shigeta Y
Endocrinol Jpn; 1982 Oct; 29(5):561-6. PubMed ID: 6763563
[TBL] [Abstract][Full Text] [Related]
38. Insulin binding of erythrocytes in hypoinsulinemic diabetics and its relationship to metabolic states.
Oka Y; Ezaki O; Akanuma Y; Kosaka K
Endocrinol Jpn; 1981 Oct; 28(5):615-22. PubMed ID: 7047154
[TBL] [Abstract][Full Text] [Related]
39. Sulfonylureas do not affect insulin binding or glycemic control in insulin-dependent diabetics.
Grunberger G; Ryan J; Gorden P
Diabetes; 1982 Oct; 31(10):890-6. PubMed ID: 6759222
[TBL] [Abstract][Full Text] [Related]
40. Rapid and slow rate of decrease in HbA1a + b and HbA1c during improved glycaemic control.
Arnqvist H; Cederblad G; Hermansson G; Ludvigsson J; Wettre S
Scand J Clin Lab Invest; 1982 May; 42(3):265-71. PubMed ID: 6753098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
